Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Symptomatic Critical Limb Ischemia”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Not applicableUnknownNCT03909022
What this trial is testing

Assessing Best Medical Treatment Patterns of Patients With Symptomatic Peripheral Arterial Occlusive Disease in Germany

Who this might be right for
Peripheral Artery DiseaseIntermittent ClaudicationCritical Limb Ischemia
Universitätsklinikum Hamburg-Eppendorf 60,000
Post-approval studies (Phase 4)Study completedNCT00906022
What this trial is testing

Self Expanding Nitinol Stent Versus Percutaneous Transluminal Arterial Angioplasty (PTA) With Optional Bailout Stenting in Case of PTA Failure in Patients With Symptomatic Critical Limb Ischemia or Severe Intermittent Claudication (EXPAND)

Who this might be right for
Patients With Symptomatic Critical Limb IschemiaSevere Intermittent Claudication
Biotronik AG 94
Not applicableLooking for participantsNCT07472049
What this trial is testing

Symptomatic and Systemic Atherosclerotic Plaque Activity in Patients With Peripheral Arterial Disease Using Novel Imaging

Who this might be right for
Peripheral Arterial DiseaseChronic Limb Threatening Ischemia
University of Edinburgh 100
Large-scale testing (Phase 3)UnknownNCT04229264
What this trial is testing

Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients.

Who this might be right for
Critical Limb Ischemia
Science Valley Research Institute 200
Large-scale testing (Phase 3)Looking for participantsNCT04433572
What this trial is testing

Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee

Who this might be right for
Peripheral Artery DiseaseCritical Limb Ischemia
Mercator MedSystems, Inc. 250